Tests begin on new drink-busting drug
The potential value of a pill to battle the effects of intoxication is huge, both in health and in social terms
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Scientists are working on a drug that appears to prevent drunkenness.
In experiments in the US, dozens of men aged 21 to 35 will be given iomazenil, followed by alcohol, and will then be allowed to "drive" on a simulator.
According to the research team led by Deepak D'Souza – of the Veterans Affairs Connecticut Healthcare System and Yale School of Medicine – the drug is believed to block receptors in the brain that process alcohol. If it turns out that the drug does block or slow the effect of alcohol in getting people drunk, it could pave the way for a pill for alcoholics and binge drinkers fighting their affliction.
Dr D'Souza told The IoS last night that he was "cautiously optimistic" of success.
The potential value of such a medication is huge. In 2010 there were 8,790 alcohol-related deaths in the UK.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments